U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07786779) titled 'A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection' on Aug. 23.
Brief Summary: A phase 1 study to evaluate the safety and tolerability of a single administration of YKYY033 injection in healthy adult participants
Study Start Date: July 10
Study Type: INTERVENTIONAL
Condition:
Venous Thromboembolism (VTE)
Intervention:
DRUG: YKYY033 Injection
subcutaneous injection, a single subcutaneous injection of the corresponding dose of YKYY033 injection
DRUG: YKYY033 Placebo
subcutaneous injection, a single subcutaneous injection of the corresponding dose of YKYY033...